Publications by authors named "Gregory Stone"

Claim this Profile
M
Microbiological, Clinical, and Pharmacokinetic/Pharmacodynamic Data to Support EUCAST Aztreonam-Avibactam Minimum Inhibitory Concentration Susceptibility Breakpoints Against Enterobacterales.
Susan R Raber, Rujia Xie, Halley Rogers, Elena Soto, Francis F Arhin, Gregory G Stone

Infect Dis Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study of Ceftazidime-Avibactam for the treatment of disease caused by bacteria: a plain language summary.
Alex Soriano, Philippe Montravers, Matteo Bassetti, Galina Klyasova, George Daikos, Gregory Stone

Future Microbiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Ceftazidime-Avibactam in Neonates and Young Infants: A Phase 2a, Multicenter Prospective Trial.
John Bradley, Emmanuel Roilides, Margaret Tawadrous, Jean Li Yan, Elena Soto, Gregory G Stone

J Pediatric Infect Dis Soc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftazidime-avibactam for the treatment of Pseudomonas aeruginosa: a plain language summary.
Pattarachai Kiratisin, Marie Kempf, Gregory Stone, Eric Utt

Future Microbiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crowned Dens Syndrome Presenting as Failure to Thrive in a Patient With Moderate Cognitive Impairment.
Gustavo Castellanos, Gregory L Stone, Amir A Razmjou

Cureus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial Arrhythmias in Patients With Pulmonary Hypertension.
Kyle O'Meara, Gregory Stone, Eric Buch, Adam Brownstein, Rajan Saggar

Chest· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
activity of ceftazidime-avibactam and comparators against OXA-48-like Enterobacterales collected between 2016 and 2020.
Gregory Stone, Mark Wise, Eric Utt

Microbiol Spectr· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum for Estabrook et al., "Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Collected as Part of a Global Surveillance Study, 2018 to 2019".
Mark Estabrook, Astrid Muyldermans, Daniel Sahm, Denis Pierard, Gregory Stone

Antimicrob Agents Chemother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant pneumonia.
Antoní Torres, Alona Kuraieva, Gregory G Stone, Catia Cillóniz

Eur Respir Rev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.
Antoni Torres, Michele Wible, Margaret Tawadrous, Paurus Irani, Gregory G Stone

J Antimicrob Chemother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of the effect of metabolic syndrome on outcomes due to acute respiratory distress syndrome: a protocol.
Gregory Stone, Andre Sisk, Margo Brown, Amy Corder, Kevin Tea

BMJ Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftazidime-avibactam and comparators against Pseudomonas aeruginosa isolates collected globally and in each geographical region between 2017-2020.
Pattarachai Kiratisin, Marie Kempf, Gregory Stone, Eric Utt

J Glob Antimicrob Resist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019.
Ana C Gales, Gregory Stone, Daniel F Sahm, Mark G Wise, Eric Utt

J Antimicrob Chemother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination.
Michael D Huband, Kelley A Fedler, Helio S Sader, Gregory G Stone, Mariana Castanheira

J Clin Microbiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Collected as Part of a Global Surveillance Study, 2018 to 2019.
Mark Estabrook, Astrid Muyldermans, Daniel Sahm, Denis Pierard, Gregory Stone

Antimicrob Agents Chemother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The primary pharmacology of ceftazidime/avibactam: microbiology from clinical studies, and development of resistance during treatment.
Wright W Nichols, Patricia A Bradford, Gregory G Stone

J Antimicrob Chemother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The primary pharmacology of ceftazidime/avibactam: resistance in vitro.
Wright W Nichols, Sushmita D Lahiri, Patricia A Bradford, Gregory G Stone

J Antimicrob Chemother· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use and Effectiveness of Ceftazidime-Avibactam in Real-World Clinical Practice: EZTEAM Study.
Alex Soriano, Philippe Montravers, Matteo Bassetti, Galina Klyasova, George Daikos, Gregory Stone

Infect Dis Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program.
James A Karlowsky, Meredith A Hackel, Gregory G Stone, Daniel F Sahm

Antimicrob Agents Chemother· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftazidime-avibactam activity against Gram-negative respiratory isolates collected between 2018 and 2019.
Marie Kempf, Francis F Arhin, Gregory Stone, Eric Utt

J Glob Antimicrob Resist· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial Activity of Ceftazidime-Avibactam and Comparators Against Fluoroquinolone-Resistant Collected Globally from Antimicrobial Testing Leadership and Surveillance: 2018-2019.
Pattarachai Kiratisin, Francis F Arhin, Gregory Stone, Eric Utt

Microb Drug Resist· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019.
Gian Maria Rossolini, Gregory Stone, Michal Kantecki, Francis F Arhin

J Glob Antimicrob Resist· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The primary pharmacology of ceftazidime/avibactam: in vitro translational biology.
Wright W Nichols, Patricia A Bradford, Sushmita D Lahiri, Gregory G Stone

J Antimicrob Chemother· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbapenem-resistant Enterobacterales and causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018-20).
James A Karlowsky, Samuel K Bouchillon, Ramy El Mahdy Kotb, Naglaa Mohamed, Gregory G Stone

JAC Antimicrob Resist· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy-Onset Ulcerative Colitis in a Pediatric Patient Presenting With Altered Mental Status and Severe Anemia.
Alda Huang, Gregory L Stone, Brian Gordon, Gina J Kim

Cureus· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis